Literature DB >> 26282222

A Meta-Analysis of Executive Dysfunction and Antidepressant Treatment Response in Late-Life Depression.

Monique A Pimontel1, David Rindskopf2, Bret R Rutherford3, Patrick J Brown3, Steven P Roose3, Joel R Sneed4.   

Abstract

OBJECTIVE: Depressed older adults with executive dysfunction (ED) may respond poorly to antidepressant treatment. ED is a multifaceted construct and different studies have measured different aspects of ED, making it unclear which aspects predict poor response. Meta-analytic methods were used to determine whether ED predicts poor antidepressant treatment response in late-life depression and to determine which domains of executive functioning are responsible for this relationship.
METHODS: A Medline search was conducted to identify regimented treatment trials contrasting executive functioning between elderly responders and nonresponders; only regimented treatment trials for depressed outpatients aged 50 and older were included. Following the most recent PRISMA guidelines, 25 measures of executive functioning were extracted from eight studies. Six domains were identified: cognitive flexibility, planning and organization, response inhibition, selective attention, verbal fluency, and the Dementia Rating Scale Initiation/Perseveration composite score (DRS I/P). Hedge's g was calculated for each measure of executive functioning. A three-level Bayesian hierarchical linear model (HLM) was used to estimate effect sizes for each domain of executive functioning.
RESULTS: The effect of planning and organization was significantly different from zero (Bayesian HLM estimate of domain effect size: 0.91; 95% CI: 0.32-1.58), whereas cognitive flexibility, response inhibition, selective attention, verbal fluency, and the DRS I/P composite score were not.
CONCLUSION: The domain of planning and organization is meaningfully associated with poor antidepressant treatment response in late-life depression. These findings suggest that therapies that focus on planning and organization may provide effective augmentation strategies for antidepressant nonresponders with late-life depression.
Copyright © 2016 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Executive dysfunction; antidepressant treatment; late-life depression; meta-analysis

Mesh:

Substances:

Year:  2015        PMID: 26282222      PMCID: PMC4928373          DOI: 10.1016/j.jagp.2015.05.010

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  61 in total

1.  The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: a latent variable analysis.

Authors:  A Miyake; N P Friedman; M J Emerson; A H Witzki; A Howerter; T D Wager
Journal:  Cogn Psychol       Date:  2000-08       Impact factor: 3.468

2.  Latent structure of the Wisconsin Card Sorting Test: a confirmatory factor analytic study.

Authors:  Kevin W Greve; Timothy R Stickle; Jeffrey M Love; Kevin J Bianchini; Matthew S Stanford
Journal:  Arch Clin Neuropsychol       Date:  2005-05       Impact factor: 2.813

3.  Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial.

Authors:  Yvette I Sheline; Carl F Pieper; Deanna M Barch; Kathleen Welsh-Bohmer; Kathleen Welsh-Boehmer; Robert C McKinstry; James R MacFall; Gina D'Angelo; Keith S Garcia; Kenneth Gersing; Consuelo Wilkins; Warren Taylor; David C Steffens; Ranga R Krishnan; P Murali Doraiswamy
Journal:  Arch Gen Psychiatry       Date:  2010-03

Review 4.  Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.

Authors:  Mark Sinyor; Anthony J Levitt; Amy H Cheung; Ayal Schaffer; Alex Kiss; Yekta Dowlati; Krista L Lanctôt
Journal:  J Clin Psychiatry       Date:  2010-01-26       Impact factor: 4.384

5.  The effects of memory, attention, and executive dysfunction on outcomes of depression in a primary care intervention trial: the PROSPECT study.

Authors:  Hillary R Bogner; Martha L Bruce; Charles F Reynolds; Benoit H Mulsant; Mark S Cary; Knashawn Morales; George S Alexopoulos
Journal:  Int J Geriatr Psychiatry       Date:  2007-09       Impact factor: 3.485

6.  Executive function and short-term remission of geriatric depression: the role of semantic strategy.

Authors:  Sarah Shizuko Morimoto; Faith M Gunning; Christopher F Murphy; Dora Kanellopoulos; Robert E Kelly; George S Alexopoulos
Journal:  Am J Geriatr Psychiatry       Date:  2011-02       Impact factor: 4.105

7.  A preliminary study of left frontal region error negativity and symptom improvement in geriatric depression.

Authors:  Balu Kalayam; George S Alexopoulos
Journal:  Am J Psychiatry       Date:  2003-11       Impact factor: 18.112

Review 8.  Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.

Authors:  George I Papakostas; Maurizio Fava
Journal:  Eur Neuropsychopharmacol       Date:  2008-09-26       Impact factor: 4.600

9.  Prefrontal neuropsychological predictors of treatment remission in late-life depression.

Authors:  Guy G Potter; Joshua D Kittinger; H Ryan Wagner; David C Steffens; K Ranga Rama Krishnan
Journal:  Neuropsychopharmacology       Date:  2004-12       Impact factor: 7.853

10.  The pattern and course of cognitive impairment in late-life depression.

Authors:  S Köhler; A J Thomas; N A Barnett; J T O'Brien
Journal:  Psychol Med       Date:  2009-08-06       Impact factor: 7.723

View more
  26 in total

Review 1.  [Depression in old age, part 2 : Comorbidity and treatment].

Authors:  Dirk K Wolter
Journal:  Z Gerontol Geriatr       Date:  2016-02-11       Impact factor: 1.281

Review 2.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly.

Authors:  Glenda M MacQueen; Benicio N Frey; Zahinoor Ismail; Natalia Jaworska; Meir Steiner; Ryan J Van Lieshout; Sidney H Kennedy; Raymond W Lam; Roumen V Milev; Sagar V Parikh; Arun V Ravindran
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

Review 3.  Opioid modulation of cognitive impairment in depression.

Authors:  Moriah L Jacobson; Hildegard A Wulf; Caroline A Browne; Irwin Lucki
Journal:  Prog Brain Res       Date:  2018-09-18       Impact factor: 2.453

Review 4.  Antidepressant pharmacotherapy in old-age depression-a review and clinical approach.

Authors:  Nathalie Pruckner; Vjera Holthoff-Detto
Journal:  Eur J Clin Pharmacol       Date:  2017-03-10       Impact factor: 2.953

5.  Older Adults' Perspectives on Clinical Research: A Focus Group and Survey Study.

Authors:  Eric J Lenze; Alex Ramsey; Patrick J Brown; Charles F Reynolds; Benoit H Mulsant; Helen Lavretsky; Steven P Roose
Journal:  Am J Geriatr Psychiatry       Date:  2016-07-29       Impact factor: 4.105

6.  Psychosocial Treatment Options for Major Depressive Disorder in Older Adults.

Authors:  Brenna N Renn; Patricia A Areán
Journal:  Curr Treat Options Psychiatry       Date:  2017-02-08

7.  Toward Prevention of Mild Cognitive Impairment in Older Adults With Depression: An Observational Study of Potentially Modifiable Risk Factors.

Authors:  Damien Gallagher; Alex Kiss; Krista L Lanctot; Nathan Herrmann
Journal:  J Clin Psychiatry       Date:  2018-11-27       Impact factor: 4.384

8.  Intervention Research in Late-Life Depression: Challenges and Opportunities.

Authors:  Helen Lavretsky
Journal:  Am J Geriatr Psychiatry       Date:  2015-11-04       Impact factor: 4.105

9.  Sex difference in prevalence of depression after stroke.

Authors:  Liming Dong; Brisa N Sánchez; Lesli E Skolarus; Eric Stulberg; Lewis B Morgenstern; Lynda D Lisabeth
Journal:  Neurology       Date:  2020-04-20       Impact factor: 9.910

10.  Transcranial Magnetic Stimulation Indices of Cortical Excitability Enhance the Prediction of Response to Pharmacotherapy in Late-Life Depression.

Authors:  Jennifer I Lissemore; Benoit H Mulsant; Anthony J Bonner; Meryl A Butters; Robert Chen; Jonathan Downar; Jordan F Karp; Eric J Lenze; Tarek K Rajji; Charles F Reynolds; Reza Zomorrodi; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2021-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.